Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Chem Biol. 2011 Jan 28;18(1):48-57. doi: 10.1016/j.chembiol.2010.11.007.

Peptide length and leaving-group sterics influence potency of peptide phosphonate protease inhibitors.

Author information

  • 1Graduate Group in Biochemistry and Molecular Biology, University of California, San Francisco, CA 94158, USA.

Abstract

The ability to follow enzyme activity in a cellular context represents a challenging technological frontier that impacts fields ranging from disease pathogenesis to epigenetics. Activity-based probes (ABPs) label the active form of an enzyme via covalent modification of catalytic residues. Here we present an analysis of parameters influencing potency of peptide phosphonate ABPs for trypsin-fold S1A proteases, an abundant and important class of enzymes with similar substrate specificities. We find that peptide length and stability influence potency more than sequence composition and present structural evidence that steric interactions at the prime-side of the substrate-binding cleft affect potency in a protease-dependent manner. We introduce guidelines for the design of peptide phosphonate ABPs and demonstrate their utility in a live-cell labeling application that specifically targets active S1A proteases at the cell surface of cancer cells.

Copyright © 2011 Elsevier Ltd. All rights reserved.

PMID:
21276938
[PubMed - indexed for MEDLINE]
PMCID:
PMC3074588
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk